Article
Pfizer looks beyond COVID after quarterly loss on Paxlovid charge
Rating:
0.0
Views:
37
Likes:
1
Library:
1
Pfizer on Tuesday urged investors to focus on growth in non-COVID products such as the new RSV vaccine Abrysvo as slumping demand for COVID-19 vaccines and treatments pushed the drugmaker to its first quarterly loss since 2019.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value